BHB acts as an endogenous NLRP3 inflammasome inhibitor, reducing inflammatory responses, and increasing circulating BHB levels may treat NLRP3 inflammasome-related cardiovascular diseases [99]. The gene discussed is NLRP3; the disease is cardiovascular disorder.